|
|
|
|

|
Home >> Investor Relations >> Corporate Governance >> Insider Transactions
Insider Transactions
| Date |
Name |
Title |
Type  |
Shares Traded |
Price Range |
| Jul 27, 2007 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
17,800 |
11.26 - 11.50 |
| Jul 25, 2007 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
29,700 |
11.35 - 11.50 |
| Jul 26, 2007 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
3,896 |
11.19 - 11.42 |
| Jul 26, 2007 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
4,104 |
11.44 - 11.50 |
| Jun 28, 2007 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
4,281 |
11.48 - 11.50 |
| Jun 29, 2007 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
13,900 |
11.41 - 11.50 |
| Jul 17, 2012 |
glaxosmithkline plc |
Beneficial Owner (10% or more) |
Buy |
2,949,581 |
6.30 |
| Mar 7, 2012 |
kramlich c richard |
Beneficial Owner (10% or more) |
Buy |
1,140,000 |
5.70 |
| Mar 7, 2012 |
new enterprise associates 11 lp |
Beneficial Owner (10% or more) |
Buy |
925,154 |
5.70 |
| Mar 7, 2012 |
newhall charles w iii |
Beneficial Owner (10% or more) |
Buy |
1,140,000 |
5.70 |
| Mar 7, 2012 |
perry mark w |
Beneficial Owner (10% or more) |
Buy |
1,140,000 |
5.70 |
| Aug 24, 2007 |
sblendorio glenn |
Director |
Buy |
1,000 |
11.39 - 11.44 |
| Jul 27, 2007 |
topper james n |
Director |
Buy |
17,800 |
11.26 - 11.50 |
| Aug 8, 2007 |
topper james n |
Director |
Buy |
29,600 |
11.50 |
| Jul 26, 2007 |
topper james n |
Director |
Buy |
4,104 |
11.44 - 11.50 |
| Jul 25, 2007 |
topper james n |
Director |
Buy |
29,700 |
11.35 - 11.50 |
| Jul 26, 2007 |
topper james n |
Director |
Buy |
3,896 |
11.19 - 11.42 |
| Jun 27, 2007 |
topper james n |
Director |
Buy |
91,612 |
11.11 - 11.50 |
| Jun 27, 2007 |
topper james n |
Director |
Buy |
52,788 |
10.95 - 11.23 |
| Jun 28, 2007 |
topper james n |
Director |
Buy |
4,734 |
11.32 - 11.47 |
|
|
Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
|
|
|
|
|
|
|